Abstract
The globally widespread genus Mycobacterium consists of about 170 species of non-spore-forming, immobile, and obligatory aerobic rod bacteria. Most of them are not pathogenic. Others are optional human pathogens such as opportunistic pathogens. The classical mycobacterioses tuberculosis and leprosy continue to present dermatologists and other physicians with complex diagnostic and therapeutic challenges. In 2016, Germany was one of the countries with a low incidence of tuberculosis, with around 6,000 cases. However, since 2014, the rate of newly infected individuals has risen again. In contrast, the number of leprosy cases has remained stable in Germany, at 0–10 cases per year in recent years. Among the non-tuberculous (atypical) mycobacterioses, swimming pool granuloma is the most common in Central Europe.
References
Tuberculosis of the Skin
Angus KJ, Roberts C, Kulkarni K et al (2007) Usefulness of the QuantiFERON test in the confirmation of latent tuberculosis in association with erythema induratum. Br J Dermatol 157:1293–1294
Braun-Falco O, Thomas P (1995) Zum Tuberkulid-Begriff aus heutiger Sicht. Hautarzt 46:383–387
Braun-Falco O, Ehring F, Kalkoff KW et al (1977) Die Tuberkulosen der Haut. Hautarzt 28:266–269
Bravo FG, Gotuzzo E (2007) Cutaneous tuberculosis. Clin Dermatol 25:173–180
Cooper AM (2009) Cell-mediated immune responses in tuberculosis. Annu Rev Immunol 27:393–422
Fox GJ, Redwood L, Chang V, Ho J (2020) The effectiveness of individual and environmental infection control measures in reducing the transmission of Mycobacterium tuberculosis: a systematic review. Clin Infect Dis ciaa719
Hallensleben NDL, de Vries HJC, Lettinga KD et al (2016) Tuberculids: cutaneous indicator diseases of Mycobacterium tuberculosis infection in young patients. J Eur Acad Dermatol Venereol 30:1590–1593
Jordaan HF, Van Niekerk DJ, Louw M (1994) Papulonecrotic tuberculid. A clinical, histopathological, and immunohistochemical study of 15 patients. Am J Dermatopathol 16:474–485
Kromer C, Fabri M, Schlapbach C, Schulze MH, Groß U, Schön MP, Buhl T (2019) Diagnosis of mycobacterial skin infections. J Dtsch Dermatol Ges 17(9):889–893
Lönnroth K, Castro K, Chakaya JM et al (2010) Tuberculosis control and elimination 2010–50: cure, care, and social development. Lancet 375:1814–1824
Martinez L, Woldu H, Chen C, Hallowell BD, Castellanos ME, Lu P, Liu Q, Whalen CC, Zhu L (2020) Transmission dynamics in tuberculosis patients with human immunodeficiency virus: a systematic review and meta-analysis of 32 observational studies. Clin Infect Dis. 2020:ciaa1146
Miggiano R, Rizzi M, Ferraris DM (2020) Mycobacterium tuberculosis pathogenesis, infection prevention and treatment. Pathogens 9(5):385
Peters F, Batinica M, Plum G et al (2016) Keim oder kein Keim: Herausforderungen bei der Diagnose mykobakterieller Infektionen der Haut. J Dtsch Dermatol Ges 14:1227–1236
Robert Koch Institut (2011) Aktiv gegen Tuberkulose – Strategien im Licht neuer Entwicklungen. Epidemiol Bull 11:81–88
Robert Koch Institut (2019) Bericht zur Epidemiologie der Tuberkulose in Deutschland für 2018. https://doi.org/10.25646/6195
Schaberg T, Bauer T, Castell S et al (2012) Empfehlungen zur Therapie, Chemoprävention und Chemoprophylaxe der Tuberkulose im Erwachsenen- und Kindesalter. Pneumologie 66:133–171
Swain SS, Sharma D, Hussain T, Pati S (2020) Molecular mechanisms of underlying genetic factors and associated mutations for drug resistance in Mycobacterium tuberculosis. Emerg Microbes Infect 9(1):1651–1663
Wulff-Woesten A, Hildebrandt U, Leverkus M (2010) Rasch metastasierender Verlauf eines “Carcinoma in lupo” bei einer Patientin mit mehr als 50 Jahre bestehendem Lupus vulgaris. J Dtsch Dermatol Ges 7:529–531
Ziegler R, Just HM, Castell S et al (2012) Infektionsprävention bei Tuberkulose – Empfehlungen des DZK. Pneumologie 66:269–282
Leprosy
Beltrame A, Barabino G, Wei Y, Clapasson A, Orza P, Perandin F, Piubelli C, Monteiro GB, Longoni SS, Rodari P, Duranti S, Silva R, Fittipaldo VA, Bisoffi Z (2020) Leprosy in refugees and migrants in Italy and a literature review of cases reported in Europe between 2009 and 2018. Microorganisms 8(8):E1113
Biedermann T, Degitz K, Schirren CG et al (1997) Leprosy type 1 reaction as the first manifestation of borderline lepromatous leprosy in a young native German. Br J Dermatol 137:1006–1010
Desikan KV, Sreevatsa (1995) Extended studies on the viability of Mycobacterium leprae outside the human body. Lepr Rev 66:287–295
Han XY, Sizer KC, Thompson EJ et al (2009) Comparative sequence analysis of Mycobacterium leprae and the new leprosy-causing Mycobacterium lepromatosis. J Bacteriol 191:6067–6074
Jopling WH, McDougall AC (eds) (1998) Handbook of leprosy. Heinemann, Oxford
Jurado F, Rodriguez O, Novales J et al (2015) Lucio’s leprosy: a clinical and therapeutical challenge. Clin Dermatol 33:66–78
Pimentel MI, Sampaio EP, Nery JA et al (1996) Borderline tuberculoid leprosy: clinical and immunological heterogeneity. Lepr Rev 67:287–296
Ploemacher T, Faber WR, Menke H, Rutten V, Pieters T (2020) Reservoirs and transmission routes of leprosy; a systematic review. PLoS Negl Trop Dis 14(4):e0008276
Rodrigues LC, Lockwood DNJ (2011) Leprosy now: epidemiology, progress, challenges, and research gaps. Lancet Infect Dis 11:464–470
Schuenemann VJ, Singh P, Mendum TA et al (2013) Genome-wide comparison of medieval and modern Mycobacterium leprae. Science 341:179–183
Walsh DS, Portaels F, Meyers WM et al (2010) Recent advances in leprosy and Buruli ulcer (Mycobacterium ulcerans infection). Curr Opin Infect Dis 23:445–455
Skin Infections by Other Mycobacteria
Aubry A, Khozidov O, Caumes E et al (2002) Sixty-three cases of Mycobacterium marinum infection. Arch Intern Med 162:1746–1752
Elston DN (2009) Nontuberculous mycobacterial skin infections. Am J Clin Dermatol 10:281–285
Emmerich K, Fabri M (2017) Atypische Mykobakterien. Hautarzt 68:403–411
Freyne B, Curtis N (2017) Mycobacterium gordonae skin infection in an immunocompetent child. Pediatr Infect Dis J 36:523–525
Griffith DE, Aksamit T, Brown-Elliott BA (2007) An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175:367–416
Herzmann C, Lange C (2010) Nicht-tuberkulöse Mykobakteriosen bei der HIV-Infektion. Dtsch Med Wochenschr 135:1192–1197
Johnson PDR, Hayman JA, Quek TY et al (2007) Consensus recommendations for the diagnosis, treatment and control of Mycobacterium ulcerans infection (Bairnsdale or Buruli ulcer) in Victoria, Australia. Med J Aust 186:64–68
Meoli A, Deolmi M, Iannarella R, Esposito S (2020) Non-tuberculous mycobacterial diseases in children. Pathogens 9(7):553
O’Brien CR, Handasyde KA, Hibble J et al (2014) Clinical, microbiological and pathological findings of Mycobacterium ulcerans infection in three Australian possum species. PLoS Negl Trop Dis 8:e2666
Palenque E (2000) Skin disease and nontuberculous atypical mycobacteria. Int J Dermatol 39:669–666
Röltgen K, Pluschke G (2020) Buruli ulcer: the efficacy of innate immune Defense may be a key determinant for the outcome of infection with Mycobacterium ulcerans. Front Microbiol 11:1018
Schlapbach C, Sendi P (2017) Serrated marine nose. N Engl J Med 376:267
Schönfeld N, Haas W, Richter E et al (2013) Empfehlungen zur Diagnostik und Therapie nichttuberkulöser Mykobakteriosen des Deutschen Zentralkomitees zur Bekämpfung der Tuberkulose (DZK) und der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP). Pneumologie 67:605–633
To K, Cao R, Yegiazaryan A, Owens J, Venketaraman V (2020) General overview of nontuberculous mycobacteria opportunistic pathogens: Mycobacterium avium and Mycobacterium abscessus. J Clin Med 9(8):E2541
Uslan DZ, Kowalski TJ, Wengenack NL et al (2006) Skin and soft tissue infections due to rapidly growing mycobacteria: comparison of clinical features, treatment, and susceptibility. Arch Dermatol 142:1287–1292
Walsh DS, Portaels F, Meyers WM (2010) Recent advances in leprosy and Buruli ulcer (Mycobacterium ulcerans infection). Curr Opin Infect Dis 23:445–455
First Describer
Bazin E (1861) Leçons théoretiques et cliniques sur la scrofule. Delahaye, Paris, p 145
Darier J (1896) Des “tuberculides” cutanées. Ann Dermatol Syphilgr (Paris) 7:1431–1436
Hansen GHA (1874) Untersuchungen zur Ursache der Lepra (norwegisch). Norsk Mag Laegervidenskaben 4:1–88
von Hebra F (1860) Handbuch der speciellen Pathologie und Therapie, vol 3. Enke, Stuttgart, p 311
Koch R (1882) Die Ätiologie der Tuberkulose. Berl Klin Wochenschr 19:221–230
Lucio R, Alvarado I (1852) Opusculo sobre el mal de San Lazaro o Elefantiasis de los Griegos. M. Murguia y Cia, Mexico
MacCallum T, Tolhurst JC, Buckle G et al (1948) A new mycobacterial infection in man. J Pathol Bacteriol 60:93
Norden A, Linell FA (1951) A new type of pathogenic mycobacterium. Nature 168:826
Riehl G, Paltauf R (1886) Tuberculosis verrucosa cutis. Eine bisher noch nicht beschriebene Form von Hauttuberculose. Arch Dermatol Syph 18:19–49
Villemin JA (1868) Études expérimentales et cliniques sur tuberculose. Ballière, Paris
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2021 Springer-Verlag GmbH Germany, part of Springer Nature
About this entry
Cite this entry
Buhl, T., Schön, M.P. (2021). Mycobacterial Infections of the Skin. In: Plewig, G., French, L., Ruzicka, T., Kaufmann, R., Hertl, M. (eds) Braun-Falco´s Dermatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-58713-3_15-1
Download citation
DOI: https://doi.org/10.1007/978-3-662-58713-3_15-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-58713-3
Online ISBN: 978-3-662-58713-3
eBook Packages: Springer Reference MedicineReference Module Medicine